Confluent Medical Technologies Names Tom Testa as Chief Operating Officer

SCOTTSDALE, Ariz., May 01, 2026 (GLOBE NEWSWIRE) -- Confluent Medical Technologies, Inc. (“Confluent”), a leading medical device and materials science contract manufacturer specializing in Nitinol and polymer components, today announced that Tom Testa, has been appointed as Chief Operating Officer ("COO") for the company, effective April 29th, 2026.